Effect of Hormone Replacement Therapy on Chronic Rhinosinusitis Management
The Laryngoscope · 2024
DOI: 10.1002/lary.31433 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Laryngoscope, 2024. Verfasst von Kevin Herrera und 3 weiteren Autor:innen. Beteiligte Einrichtung: Keck School of Medicine, University of Southern California, Los Angeles, California, U.S.A. Hauptthemen laut MEDLINE: Hormone Replacement Therapy, Rhinosinusitis. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCATS NIH HHS, National Center for Advancing Translational Science (NCATS), National Center for Advancing Translational Sciences.
Abstract (Originalsprache)
Objectives
To investigate whether hormone replacement therapy (HRT) impacts health care resource utilization in the management of chronic rhinosinusitis (CRS) in older women.
Methods
Using the TriNetX US health record database, women 55 years or older with a diagnosis of CRS were included and followed for 3 years. The cohort was stratified into two groups: women who received HRT at the beginning of the study were compared to women who did not receive HRT. The groups were matched by age, race, ethnicity, history of asthma, and history of nasal polyps. Outcomes included whether the patient underwent endoscopic sinus surgery (ESS) and frequency of antibiotic use. Measures of association, Kaplan–Meier analysis, and cohort descriptive statistics were calculated.
Results
Of the 65,400 women included, the mean age was 66.9 years. 27.0% and 3.6% of patients had a history of asthma or nasal polyps, respectively. Overall, 2.0% of CRS patients underwent ESS, with the HRT group less likely to undergo ESS [OR: 0.28; 95% CI: (0.25–0.32)] compared to patients who did not receive HRT. When stratified by polyp status, HRT patients with nasal polyps had a greater decrease in ESS rates compared to control than HRT patients without nasal polyps. The HRT group had a higher mean number of antibiotic prescriptions compared to the non‐HRT group.
Conclusion
HRT is associated with decreased utilization of ESS to treat CRS, with a greater effect size for ESS among CRSwNP patients. However, HRT was associated with higher antibiotic utilization. Level of Evidence 3 Laryngoscope , 134:3921–3926, 2024
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Keck School of Medicine, University of Southern California, Los Angeles, California, U.S.A.
- Caruso Department of Otolaryngology-Head and Neck Surgery, Keck School of Medicine of University of Southern California, Los Angeles, California, U.S.A.
ORCID-Profile: Kevin Hur
Förderung
- NCATS NIH HHS
- National Center for Advancing Translational Science (NCATS)
- National Center for Advancing Translational Sciences
Zitieren
APA
Herrera, K., Parikh, M., Vemula, S., & Hur, K. (2024). Effect of Hormone Replacement Therapy on Chronic Rhinosinusitis Management. The Laryngoscope. https://doi.org/10.1002/lary.31433
Vancouver
Herrera K, Parikh M, Vemula S, Hur K. Effect of Hormone Replacement Therapy on Chronic Rhinosinusitis Management. The Laryngoscope. 2024. doi:10.1002/lary.31433
BibTeX
@article{Herrera2024,
author = {Herrera, Kevin and Parikh, Miti and Vemula, Sahiti and Hur, Kevin},
title = {Effect of Hormone Replacement Therapy on Chronic Rhinosinusitis Management},
journal = {The Laryngoscope},
year = {2024},
doi = {10.1002/lary.31433}
}
EUVIMED